Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Sellas Life Sciences Group Inc (SLS)

Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia GlobeNewswire - Tue Dec 10, 7:30AM CST

SLS : 0.8880 (-1.11%)
SELLAS Life Sciences Reports Promising Data from Phase 2 Trial of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Quiver Quantitative, Inc. - Mon Dec 9, 5:54PM CST

SELLAS reports median overall survival over 7.7 months and a 56% overall response rate for AML patients using SLS009.Quiver AI SummarySELLAS Life Sciences Group, Inc. has released promising new data from...

SLS : 0.8880 (-1.11%)
SELLAS Announces Positive Overall Survival and Overall Response Rate Data from the Phase 2 Trial of SLS009 in r/r AML GlobeNewswire - Mon Dec 9, 7:45AM CST

SLS : 0.8880 (-1.11%)
SELLAS Life Sciences Group Identifies ASXL1 Mutations as Predictive Biomarkers for SLS009 Efficacy in Solid Cancers Quiver Quantitative, Inc. - Wed Nov 27, 5:52PM CST

SELLAS Life Sciences reports high efficacy of SLS009 in ASXL1 mutated solid cancers, supporting targeted clinical trials.Quiver AI SummarySELLAS Life Sciences Group, Inc. has announced promising preclinical...

SLS : 0.8880 (-1.11%)
SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers GlobeNewswire - Wed Nov 27, 7:45AM CST

SLS : 0.8880 (-1.11%)
SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Nov 13, 3:15PM CST

SLS : 0.8880 (-1.11%)
SELLAS Life Sciences to Present at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition 2024 GlobeNewswire - Tue Nov 5, 8:55AM CST

SLS : 0.8880 (-1.11%)
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia GlobeNewswire - Tue Oct 15, 7:45AM CDT

SLS : 0.8880 (-1.11%)
SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit GlobeNewswire - Thu Oct 10, 3:05PM CDT

SLS : 0.8880 (-1.11%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase FinancialNewsMedia - Mon Jun 17, 8:45AM CDT

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END

ATNM : 1.2900 (+15.18%)
BPTH : 1.2600 (-15.44%)
LGVN : 1.6500 (+3.12%)
SLS : 0.8880 (-1.11%)
BMY : 57.33 (+1.83%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot